Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1981 2
1982 4
1983 1
1984 3
1985 6
1986 2
1988 1
1989 2
1991 2
1992 1
1993 1
1994 2
1995 2
1996 3
1997 1
1998 3
1999 3
2001 1
2002 1
2003 12
2004 7
2005 10
2006 10
2007 21
2008 12
2009 11
2010 19
2011 21
2012 16
2013 32
2014 19
2015 14
2016 28
2017 22
2018 22
2019 25
2020 23
2021 34
2022 28
2023 24
2024 18
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

443 results

Results by year

Filters applied: . Clear all
Page 1
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer.
Chesner LN, Polesso F, Graff JN, Hawley JE, Smith AK, Lundberg A, Das R, Shenoy T, Sjöström M, Zhao F, Hu YM, Linder S, Chen WS, Hawkins RM, Shrestha R, Zhu X, Foye A, Li H, Kim LM, Bhalla M, O'loughlin T, Kuzuoglu-Ozturk D, Hua JT, Badura ML, Wilkinson S, Trostel SY, Bergman AM, Ruggero D, Drake CG, Sowalsky AG, Fong L, Cooperberg MR, Zwart W, Guan X, Ashworth A, Xia Z, Quigley DA, Gilbert LA, Feng FY, Moran AE. Chesner LN, et al. Among authors: hu ym. Cancer Discov. 2025 Mar 3;15(3):481-494. doi: 10.1158/2159-8290.CD-24-0559. Cancer Discov. 2025. PMID: 39652470 Free PMC article.
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial.
Zhao FH, Wu T, Hu YM, Wei LH, Li MQ, Huang WJ, Chen W, Huang SJ, Pan QJ, Zhang X, Hong Y, Zhao C, Li Q, Chu K, Jiang YF, Li MZ, Tang J, Li CH, Guo DP, Ke LD, Wu X, Yao XM, Nie JH, Lin BZ, Zhao YQ, Guo M, Zhao J, Zheng FZ, Xu XQ, Su YY, Zhang QF, Sun G, Zhu FC, Li SW, Li YM, Pan HR, Zhang J, Qiao YL, Xia NS. Zhao FH, et al. Among authors: hu ym. Lancet Infect Dis. 2022 Dec;22(12):1756-1768. doi: 10.1016/S1473-3099(22)00435-2. Epub 2022 Aug 26. Lancet Infect Dis. 2022. PMID: 36037823 Clinical Trial.
PROX1 is an early driver of lineage plasticity in prostate cancer.
Duan Z, Shi M, Kumaraswamy A, Lin D, Khokhani D, Wang Y, Zhang C, Flores D, Rodansky E, Swaim OA, Storck WK, Beck HN, Patel RA, Sayar E, Hanratty BP, Xue H, Dong X, Maylin ZR, Wan R, Quigley DA, Sjöström M, Hu YM, Zhao F, Xia Z, Cheng S, Yu X, Feng FY, Zhang L, Aggarwal R, Small EJ, Ravikumar V, Rao A, Bedi K, Lee JK, Morrissey C, Coleman I, Nelson PS, Corey E, Udager AM, Rebernick RJ, Cieslik MP, Chinnaiyan AM, Yates JA, Haffner MC, Wang Y, Alumkal JJ. Duan Z, et al. Among authors: hu ym. J Clin Invest. 2025 Jun 2;135(11):e187490. doi: 10.1172/JCI187490. eCollection 2025 Jun 2. J Clin Invest. 2025. PMID: 40454483 Free PMC article.
Non-Hermitian Edge Burst.
Xue WT, Hu YM, Song F, Wang Z. Xue WT, et al. Among authors: hu ym. Phys Rev Lett. 2022 Mar 25;128(12):120401. doi: 10.1103/PhysRevLett.128.120401. Phys Rev Lett. 2022. PMID: 35394323
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.
Kumaraswamy A, Duan Z, Flores D, Zhang C, Sehrawat A, Hu YM, Swaim OA, Rodansky E, Storck WK, Kuleape JA, Bedi K, Mannan R, Wang XM, Udager A, Ravikumar V, Bankhead A 3rd, Coleman I, Lee JK, Morrissey C, Nelson PS, Chinnaiyan AM, Rao A, Xia Z, Yates JA, Alumkal JJ. Kumaraswamy A, et al. Among authors: hu ym. JCI Insight. 2023 Aug 8;8(15):e167440. doi: 10.1172/jci.insight.167440. JCI Insight. 2023. PMID: 37440313 Free PMC article.
Androgen blockade primes NLRP3 in macrophages to induce tumor phagocytosis.
Chaudagar K, Rameshbabu S, Mei S, Hirz T, Hu YM, Argulian A, Labadie B, Desai K, Grimaldo S, Kahramangil D, Nair R, DSouza S, Zhou D, Li M, Doughan F, Chen R, Shafran J, Loyd M, Xia Z, Sykes DB, Moran A, Patnaik A. Chaudagar K, et al. Among authors: hu ym. bioRxiv [Preprint]. 2023 Oct 21:2023.09.15.557996. doi: 10.1101/2023.09.15.557996. bioRxiv. 2023. PMID: 37904975 Free PMC article. Preprint.
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer.
Kumaraswamy A, Hu YM, Yates JA, Zhang C, Rodansky E, Khokhani D, Flores D, Duan Z, Zhang Y, Tabatabaei S, Slottke R, Ye S, Lara P, Foye A, Ryan CJ, Quigley DA, Huang J, Aggarwal R, Reiter RE, Wicha MS, Beer TM, Rettig M, Gleave M, Evans CP, Witte ON, Stuart JM, Thomas GV, Feng FY, Small EJ, Xia Z, Alumkal JJ. Kumaraswamy A, et al. Among authors: hu ym. NPJ Precis Oncol. 2025 Jul 7;9(1):223. doi: 10.1038/s41698-025-01002-8. NPJ Precis Oncol. 2025. PMID: 40624104 Free PMC article.
Gravitational wave astronomy with TianQin.
Li EK, Liu S, Torres-Orjuela A, Chen X, Inayoshi K, Wang L, Hu YM, Amaro-Seoane P, Askar A, Bambi C, Capelo PR, Chen HY, Chua AJK, Condés-Breña E, Dai L, Das D, Derdzinski A, Fan HM, Fujii M, Gao J, Garg M, Ge H, Giersz M, Huang SJ, Hypki A, Liang ZC, Liu B, Liu D, Liu M, Liu Y, Mayer L, Napolitano NR, Peng P, Shao Y, Shashank S, Shen R, Tagawa H, Tanikawa A, Toscani M, Vázquez-Aceves V, Wang HT, Wang H, Yi SX, Zhang JD, Zhang XT, Zhu L, Zwick L, Huang S, Mei J, Wang Y, Xie Y, Zhang J, Luo J. Li EK, et al. Among authors: hu ym. Rep Prog Phys. 2025 May 16;88(5). doi: 10.1088/1361-6633/adc9be. Rep Prog Phys. 2025. PMID: 40194522 Review.
443 results